These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10362145)

  • 1. Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene.
    Basolo F; Fiore L; Fusco A; Giannini R; Albini A; Merlo GR; Fontanini G; Conaldi PG; Toniolo A
    Int J Cancer; 1999 Jun; 81(6):956-62. PubMed ID: 10362145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement.
    Basolo F; Giannini R; Toniolo A; Casalone R; Nikiforova M; Pacini F; Elisei R; Miccoli P; Berti P; Faviana P; Fiore L; Monaco C; Pierantoni GM; Fedele M; Nikiforov YE; Santoro M; Fusco A
    Int J Cancer; 2002 Feb; 97(5):608-14. PubMed ID: 11807785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1.
    Fiore L; Pollina LE; Fontanini G; Casalone R; Berlingieri MT; Giannini R; Pacini F; Miccoli P; Toniolo A; Fusco A; Basolo F
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4094-100. PubMed ID: 9398720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
    Kim R; Tanabe K; Uchida Y; Emi M; Toge T
    Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
    Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
    Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.
    Sekharam M; Zhao H; Sun M; Fang Q; Zhang Q; Yuan Z; Dan HC; Boulware D; Cheng JQ; Coppola D
    Cancer Res; 2003 Nov; 63(22):7708-16. PubMed ID: 14633695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.
    Trisciuoglio D; Desideri M; Ciuffreda L; Mottolese M; Ribatti D; Vacca A; Del Rosso M; Marcocci L; Zupi G; Del Bufalo D
    J Cell Physiol; 2005 Dec; 205(3):414-21. PubMed ID: 15920759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies.
    Basolo F; Fiore L; Pollina L; Fontanini G; Conaldi PG; Toniolo A
    Clin Cancer Res; 1998 Feb; 4(2):381-7. PubMed ID: 9516926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of thyroid follicular cells by galectin-3.
    Takenaka Y; Inohara H; Yoshii T; Oshima K; Nakahara S; Akahani S; Honjo Y; Yamamoto Y; Raz A; Kubo T
    Cancer Lett; 2003 May; 195(1):111-9. PubMed ID: 12767519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma.
    Landriscina M; Fabiano A; Altamura S; Bagalà C; Piscazzi A; Cassano A; Spadafora C; Giorgino F; Barone C; Cignarelli M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5663-71. PubMed ID: 16030158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
    Qing J; Maher VM; Tran H; Argraves WS; Dunstan RW; McCormick JJ
    Oncogene; 1997 Oct; 15(18):2159-68. PubMed ID: 9393974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
    Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
    BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.